Disability

Shearwater Health Partners with Laguna Health, Leveraging Cutting-Edge AI Solutions

The partnership enables Shearwater to integrate advanced conversational AI and real-time insights into its Clinical Process Outsourcing operations  NASHVILLE, Tenn.,…

1 year ago

AudioEye Achieves HIPAA Compliance and SOC 2 Type II Certification, Strengthening Data Protection and Security Measures for Its Customers

New compliance and certification measures unlock opportunities in healthcare and enterprise TUCSON, Ariz., Sept. 26, 2024 /PRNewswire/ -- AudioEye, Inc. (Nasdaq:…

1 year ago

Enlivex Receives Authorization from the Danish Medicines Agency to Initiate the Phase II Stage of its Phase I/II Trial of Allocetra in Patients with Moderate to Severe Knee Osteoarthritis

Nes-Ziona, Israel, Sept. 26, 2024 (GLOBE NEWSWIRE) -- Enlivex Therapeutics Ltd. (Nasdaq: ENLV, the “Company”), a clinical-stage macrophage reprogramming immunotherapy…

1 year ago

Pacira Announces the Presentation of 104-Week Safety and Efficacy Data Following Local Administration of PCRX-201 for Moderate to Severe Osteoarthritis of the Knee

-- Poster to be presented at ACR Convergence annual meeting -- TAMPA, Fla., Sept. 26, 2024 (GLOBE NEWSWIRE) -- Pacira…

1 year ago

Emergent BioSolutions Confirms Approximately $400 million in Orders in 2024 & 2025 to Support Smallpox and Mpox Preparedness Efforts

$185+ million in incremental orders for ACAM2000® and VIGIV to be delivered in 2024 and 2025GAITHERSBURG, Md., Sept. 25, 2024…

1 year ago

Ottobock Continues Providing Technical Service for Invictus Games Vancouver Whistler 2025

The medical technology company supports competitors in the first ever Winter hybrid Invictus GamesBURLINGTON, ON / ACCESSWIRE / September 24,…

1 year ago

Ottobock Continues Technical Service for Invictus Games Vancouver Whistler 2025

The medical technology company supports competitors in the first-ever Winter hybrid Invictus GamesAUSTIN, TX / ACCESSWIRE / September 24, 2024…

1 year ago

Enlivex Announces Positive DSMB Recommendation to Initiate the Phase II Stage of its Phase I/II Trial of Allocetra in Patients with Moderate to Severe Knee Osteoarthritis

Nes-Ziona, Israel, Sept. 24, 2024 (GLOBE NEWSWIRE) -- Enlivex Therapeutics Ltd. (Nasdaq: ENLV, the “Company”), a clinical-stage macrophage reprogramming immunotherapy…

1 year ago

Potential of George Medicines’ novel, low-dose, triple combination pill to transform management of hypertension highlighted at global congress

London, UK 24 September 2024 – George Medicines, a late-stage, biopharmaceutical company addressing significant unmet need in the treatment of…

1 year ago